The immune machinery that drives the skin disease neutrophilic dermatosis (Sweet’s syndrome) reveals clues for taming the immune response
Researchers studying auditory hair cell regeneration for treatment of hearing loss looked to Mother Nature for guidance, and they were rewarded.
Normal production of blood-forming stem cells relies on short-lived migratory cells that offer clues for making donor cells in the lab.
Discovery of the protein that delays cell death could aid transplant survival and offer treatment for cancer, neurodegeneration and infection
Learn what whole genome sequencing reveals about the lifetime cancer risk of childhood cancer survivors and who may benefit from genetic screening.
Study of childhood cancer survivors shows reduction in radiation therapy leads to decline of second cancers
Changes in childhood cancer treatment, including the reduced use of radiation therapy, has reduced the risk for second cancer in survivors.
The new grant supports the opening of the St. Jude gene therapy protocol for X-linked SCID at the University of California, San Francisco (UCSF) Benioff Children's Hospital San Francisco.
Researchers craft a new approach for mining genomic data for rare genetic variations that may play a role in disease risk.
Screening for all children newly diagnosed with the high-risk leukemia AMKL to check for genetic alterations that can help guide treatment.
DNA sequencing of bacteria leads to discovery of mutation that helps VRE tolerate antibiotics
Explore more research news
More Research News
Clinical Trials Alerts
Our e-newsletter for clinicians offers updates on St. Jude open clinical trials and research news.
Courageous patients. Resolute doctors. Caring staff. Inventive scientists. Their voices come alive in Promise magazine.
Follow Us on Social Media
Connect with @stjuderesearch to keep up with our latest science and medical news. More about St. Jude social media.
Browse all scientific publications by St. Jude investigators in 2016.